In a recent The Times article, Citeline analyst Daniel Chancellor says AstraZeneca's withdrawal of its COVID-19 vaccine from the global market is largely symbolic.

Read it now: ow.ly/79OL50RASle.
(Subscription may be required.)

#COVID19Vaccine #VaccineDevelopment

Deliver life-changing treatments to patients – faster – driven by meaningful analysis and actionable insights from Citeline’s global Consulting & Analytics team. Learn more: ow.ly/ao2350RNEXZ.

Motif's “pea-sized” Digitally programmable Over-brain Therapeutic (DOT) is minimally invasive, requires 20 min to implant and can be activated at home with a wearable to “lift the fog” for people with depression.
Learn more: ow.ly/5uSC50RNH4r (Subscription may be needed.)

Increased awareness and collaboration are key to innovation. In this article, Will Maier, VP and Head of Centre for Rare Disease, ICON Biotech, explores the challenges and the solutions to advance rare disease drug development in today’s dynamic landscape. ow.ly/XSkJ50RQPjq

Not long to go! There are just two months remaining to enter the Global Generics & Biosimilars Awards 2024. We will be closing for entries on Monday, 22 July. Visit our website today to read more about the categories and entry criteria. ow.ly/nbVc50RtebY
#GGBAwards

A panel of mental health experts, advocates, and patients discussed the promise of the Neuronetics’ NeuroStar transcranial magnetic stimulation system. 'For the first time in my life, I saw true hope. If it wasn’t for NeuroStar, I wouldn't be here today.” ow.ly/QqTf50RJWyK

Join tomorrow’s webinar as we provide our annual review of trends in pharmaceutical R&D. Take the industry's temperature at the start of 2024 by assessing the pipeline and emerging drug modalities, as well as regional variations.Last chance to register: ow.ly/bz1450RH6tt.

GLP-1s have been a #pharma success story, promising to improve patient health and reshape the industry. Our blog features expert opinions from Citeline, MMIT Network, and Panalgo and the latest market forecasts from Evaluate Pharma. Read it here: ow.ly/fjKl50Rfp4I

Two months to enter the Citeline Japan Awards 2024? Don't miss out on the opportunity to gain recognition for your contributions & showcase your achievements with industry leaders from across Japan.
Entry deadline is Monday July 15. #CitelineJapanAwards citeline.com/en/awards/cite…

Global Patient Insights, the industry’s most comprehensive view of the patient landscape, integrates RWD on patient population and diversity with Sitetrove’s best-in-class intelligence to optimize the site selection process for clinical trial sponsors.

ow.ly/nfeX50RIhrO.

The landscape of clinical trial disclosures is rapidly evolving.

Join Citeline's Thomas Wicks and Francine Lane for a free webcast where they will delve into the latest trends in plain language summaries and regulatory intelligence: bit.ly/3wDdkUh

Last night I made my debut on the Citeline China Biotech podcast, where colleague Brian Yang and I discussed the BIOSECURE Act and its potential implications for the pharma industry Pink Sheet, Citeline Regulatory #pinksheet #pharma : soundcloud.com/citelinesounds…

The entry deadline for the Scrip Awards 2024 is fast approaching! There are 2 months remaining to enter – the Awards will be taking place on Wednesday 4 December 2024 at Raffles London, at the OWO.

The entry deadline is Friday 12 July #ScripAwards

ow.ly/7ITS50Rnebp

Sponsor alert! 🏆

We're thrilled to announce Pharmacloud as a sponsor for the 2024 Global Generics and Biosimilars Awards, sponsoring the Leader of the Year category! Interested in joining us as a sponsor? Reach out today!
ow.ly/8O8q50QNlG3 #GGBAwards

Social media listening has the potential to aid many facets of drug development in the quest for patient-centric therapies that are fit for purpose. Experts will discuss the use of NLP technologies to glean insights from social media for a range of topics. ow.ly/VIXC50RATJs

From supply chain efficiency to patient-centric value chain. This webinar will explore the key findings from the report, focusing specifically on the CDMO and CRO synergies that can be leveraged to streamline drug development and accelerate delivery. ow.ly/HBMU50RtzXk.

BioIndustry Association (BIA) has collaborated with Citeline to piece together a report that provides an overview of the state of the UK's cell and gene therapy sector.

Read more and view the full report here: ow.ly/aGru50QAJXV

#CellandGeneUK #LifeSciences #ClinicalTrials

Here are the winners of the 2024 Citeline Awards for the pharmaceutical/biotech industry. Congrats to all of these and the nominees #citeline #Awards #biotech #pharmaceutical Citeline scrip.citeline.com/articles/2024/…

Join us in welcoming the biosimilars council on board as supporter of the Global Generics & Biosimilars Awards 2024! #GGBAwards ow.ly/I95250RzpKf

Our final Award of the evening has been handed to Moderna and ProofPilot, winners of the Citeline Award for Clinical Partnership of the Year! Congratulations to all of tonight’s winners! #CitelineAwards ow.ly/b6Oi50Rzcqb